Editorial: Immunometabolic Regulations in Adaptive and Innate Immune Cells Shapes and Re-Directs Host Immunity. by Ho, P.C. & Hess, C.
July 2017 | Volume 8 | Article 8521
Editorial
published: 24 July 2017
doi: 10.3389/fimmu.2017.00852
Frontiers in Immunology | www.frontiersin.org
Edited and Reviewed by: 
Francesca Granucci, 
University of Milano-Bicocca, Italy
*Correspondence:
Ping-Chih Ho  
ping-chih.ho@unil.ch; 
Christoph Hess  
christoph.hess@usb.ch
Specialty section: 
This article was submitted to 
Molecular Innate Immunity, 
a section of the journal 
Frontiers in Immunology
Received: 29 June 2017
Accepted: 06 July 2017
Published: 24 July 2017
Citation: 
Ho P-C and Hess C (2017) Editorial: 
Immunometabolic Regulations in 
Adaptive and Innate Immune 
Cells Shapes and Re-Directs 
Host Immunity. 
Front. Immunol. 8:852. 
doi: 10.3389/fimmu.2017.00852
Editorial: immunometabolic 
regulations in adaptive and  
innate immune Cells Shapes  
and re-directs Host immunity
Ping-Chih Ho1,2* and Christoph Hess3*
1 Department of Fundamental Oncology, University of Lausanne, Lausanne, Switzerland, 2 Ludwig Center for  
Cancer Research, University of Lausanne, Lausanne, Switzerland, 3 Department of Biomedicine, Immunobiology,  
University of Basel, Basel, Switzerland
Keywords: immunometabolism, metabolic reprogramming, tumor microenvironment, autoimmunity, immune 
suppression
Editorial on the Research Topic
Immunometabolic Regulations in Adaptive and Innate Immune Cells Shapes and Re-Directs 
Host Immunity
MEtaBoliSM
Metabolism, a nightmare for many students and, let’s be honest, not-anymore students alike. 
Complicated pathways and crosstalks between metabolites and metabolic enzymes—with little 
tangible relation to any real-life biology. In the past two decades, however, very concrete clinical 
scenarios, such as cancer, diabetes, and immunity, have become inseparably tied to cellular metabolic 
dysregulation. With unprecedented breath and depth new technologies, such as metabolomics, 
proteomics, RNA-sequencing, and epigenomics, allowed interrogating cellular metabolism, its 
links to organismal metabolic changes, as well as its regulation and biologic importance in health 
and disease.
In this research topic, which entails 11 invited review articles, we are focusing on how metabolic 
regulation fine-tunes activation, differentiation and acquisition of effector function among both 
innate and adaptive immune cells.
Starting out, a review by Wei et al. provides an overview on how regulatory circuits of oxygen- 
and nutrient-sensing machineries orchestrate T cell responses. The authors further discuss the 
role of autophagy and the redox- and NAD+/NADH balance in T cell differentiation and activa-
tion. A review article by Gardiner and Finlay discusses the uniqueness of metabolic regulation in 
guiding NK cell activation and NK cell dependent immune responses. The work by Langston et al. 
covers, in detail, mechanisms by which distinct signals induce a metabolic shift in macrophages, 
and how such metabolic adaptation sustains signaling pathways to drive macrophage polarization. 
The authors further discuss how metabolic regulation in macrophages centers on mitochondria 
to enforce cell activation. The review by Sancho et al. discusses how mitochondrial activity, and 
in particular the dynamics of the electron transport chain, acts as a rheostat to modulate signal-
ing, transcription, and the epigenome of innate immune cells. Chao et al. go on to discuss how 
mitochondria regulate T cell activation, differentiation, and function. The authors of this paper 
further highlight how mitochondrial fitness and dynamics relate to T cell immunity in cancer, 
infection, autoimmunity, and during aging.
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Metabolism Meets Immunology
The review by Binger et  al. is focused on metabolic repro-
gramming in CD4+ helper T  cells, with a particular emphasis 
on Th17 and regulatory T cells (Tregs). The article highlights the 
metabolic demands of Th17 cells, and describes how metabolic 
regulation in Th17 cells contributes to autoimmunity. Kolev and 
Kemper then discuss the role of complement, an emerging player 
of immunometabolic regulation. The authors postulate that this 
ancient arm of the immune system may indeed have coevolved 
with immunometabolism.
The last four papers of this research topic emphasize 
contri butions of immunometabolic regulation in cancer, ath-
erosclerosis, and obesity. First, Renner et al. discuss metabolic 
communication and competition between immune- and cancer-
cells in the tumor microenvironment and propose therapeutic 
strategies to enhance anti-tumor immunity by augmenting 
metabolic fitness of tumor-infiltrating immune cells. Patsoukis 
et  al. highlight how co-inhibitory receptors tailor metabolic 
reprogramming and pathway usage in T  cell subsets. Since 
tumor-infiltrating T  cells often express co-inhibitory recep-
tors, understanding the metabolic circuits controlled by these 
receptors may provide a springboard toward reinvigorating 
cancer-directed T cell immune responses via metabolic repro-
gramming. Based on the idea that tumor-infiltrating T cells may 
face a metabolic crisis in the tumor microenvironment, Irving 
et  al. discuss how metabolic rewiring may be an attractive 
strategy for designing new T cell-based cancer immunothera-
pies, particularly chimeric antigen receptor T  cell therapies. 
In addition to T  cells, Geeraerts et  al. describe how the 
metabolic environment in tumors and in atheromatous lesions 
affects macrophage polarization and function via intervening 
with cellular metabolic processes. This article further discusses 
how altered systemic metabolism among obese individuals, and 
mice, may promote metabolic disorders, including insulin resist-
ance, by modulating inflammatory properties of adipose tissue 
macrophages.
In summary, this research topic highlights the tremendous 
progress that has been made in understanding how metabolic 
reprogramming underpins immune cell differentiation, activa-
tion, and effector function. However, and as also highlighted by 
the various contributions, key questions regarding the detailed 
molecular mechanisms by which metabolic pathways control 
immune cell responses are still unresolved. Specifically, impor-
tant metabolic checkpoints remain to be described, and it is still 
an enigma how metabolic checkpoints crosstalk to orchestrate 
immune responses. We hope that this research topic not only 
will serve as a valuable resource but also that it will also provoke 
questions and help formulating relevant next-generation research 
questions—with the ultimate goal to exploit immunometabolic 
regulation to the benefit of patients.
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